Small biotech the ‘true engine’ of antibiotic innovation, as pharma ‘spews nonsense’ on its R&D: Jim O'Neill

Health experts have rounded on pharma companies as having “endless talk and no action” when it comes to antibiotic R&D, as governments around the world continue to sound alarm bells over a potential antimicrobial resistance “apocalypse”.